The MLPA (Multiplex Ligation-dependent Probe Amplification) method for detecting dosage differences of up to 50 different nucleic acid fragments in a single reaction was first described in 2002 (Schouten et al., Nucl Acids Res 30:12e57). In this study, the copy number of 40 loci in the human genome was determined through simultaneous relative quantification. The amount of sequence-specific hybridized and ligated oligonucleotides is proportional to the copy number of the target sequence.
The amplification products are subsequently separated by size using capillary electrophoresis. Dose differences are identified by reductions or increases in heights and areas of the detected peaks.
To date, more than 300 different MLPA kits are commercially available for the detection of deletions/duplications of single exons within genes, gene regions, entire genes, chromosomal segments, and even whole chromosomes (e.g., from MRC-Holland).
Variants of the basic MLPA technique have also been developed:
●RT-MLPA (reverse transcriptase MLPA): Used for mRNA profiling.
●MS-MLPA (methylation-specific MLPA): Determines copy number and analyzes methylation patterns, enabling imprinting defect detection and tumor analysis.
WAYS TO PARTNER WITH US
TarCET IVD Kits
CE-IVD kits containing reagents
for hereditary indications in
an easy-to-use kit form
Technology Transfer
Out-of-the-box genetics workflow
from sequencing to reporting
for non-invasive prenatal testing
Contact Us
Please get in touch with us
for any questions, inquiries,
feedback, or with any
comments you might have.
BLOG ARTICLES
Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f…
Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced …
Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso…
Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co…
The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study…
Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a…
Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area…
February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th…
Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor…
Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant…
